SMT201700012B - Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi - Google Patents

Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi

Info

Publication number
SMT201700012B
SMT201700012B SM201700012T SM201700012T SMT201700012B SM T201700012 B SMT201700012 B SM T201700012B SM 201700012 T SM201700012 T SM 201700012T SM 201700012 T SM201700012 T SM 201700012T SM T201700012 B SMT201700012 B SM T201700012B
Authority
SM
San Marino
Prior art keywords
conjugates
glycosaminoglican
gag
synthesis
procedure
Prior art date
Application number
SM201700012T
Other languages
English (en)
Inventor
Este Matteo D
Davide Renier
Gianfranco Pasut
Antonio Rosato
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Publication of SMT201700012B publication Critical patent/SMT201700012B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SM201700012T 2009-06-16 2017-01-12 Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi SMT201700012B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2009A001065A IT1399351B1 (it) 2009-06-16 2009-06-16 Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi
PCT/EP2010/003634 WO2010145821A1 (en) 2009-06-16 2010-06-04 Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof

Publications (1)

Publication Number Publication Date
SMT201700012B true SMT201700012B (it) 2017-03-08

Family

ID=41571532

Family Applications (2)

Application Number Title Priority Date Filing Date
SM20170012T SMT201700012T1 (it) 2009-06-16 2010-06-04 Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi
SM201700012T SMT201700012B (it) 2009-06-16 2017-01-12 Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SM20170012T SMT201700012T1 (it) 2009-06-16 2010-06-04 Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi

Country Status (11)

Country Link
US (1) US9034624B2 (it)
EP (1) EP2443156B1 (it)
CN (1) CN102803297B (it)
BR (1) BR112012000551A2 (it)
CA (1) CA2765739C (it)
ES (1) ES2600358T3 (it)
IT (1) IT1399351B1 (it)
MX (1) MX2011013683A (it)
RU (1) RU2530649C2 (it)
SM (2) SMT201700012T1 (it)
WO (1) WO2010145821A1 (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2268673B1 (en) 2008-03-28 2017-10-25 The Regents of The University of California Polypeptide-polymer conjugates and methods of use thereof
HUE033169T2 (en) * 2011-03-03 2017-11-28 Chugai Pharmaceutical Co Ltd Amino carboxylic acid modified hyaluronic acid derivative
ITMI20121597A1 (it) * 2012-09-25 2014-03-26 Beta Pharma S A Coniugato tra frammento di parete cellulare batterica ed un veicolo mucopolisaccaridico e suoi usi in ambito medico
CN104357433A (zh) * 2014-11-03 2015-02-18 山东大学 一种6-o-季铵化壳聚糖-超氧化物歧化酶修饰物及其制备
CN104910294B (zh) * 2015-06-05 2017-08-29 西北农林科技大学 一种高分子量去乙酰化透明质酸的制备方法及其应用
ES2925248T3 (es) 2015-12-09 2022-10-14 Univ California Métodos para tratar una enfermedad o un trastorno oculares
CN106421925B (zh) * 2016-09-08 2019-01-29 中国医学科学院生物医学工程研究所 基于糖胺聚糖仿生细胞外基质水凝胶作为胰岛培养支架的制备方法
AR111190A1 (es) 2017-03-22 2019-06-12 Genentech Inc Composiciones en hidrogel de prodrogas entrecruzadas de ácido hialurónico y métodos relacionados
WO2019027765A1 (en) * 2017-08-02 2019-02-07 Northwestern University SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS AND USES THEREOF
AU2019232001B2 (en) 2018-03-09 2025-02-20 Valitor, Inc. Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation
WO2020064844A1 (en) * 2018-09-26 2020-04-02 Ascendis Pharma A/S Treatment of infections
WO2020084558A1 (en) 2018-10-26 2020-04-30 Istituto Oncologico Veneto Iov-Irccs Hyaluronic acid as a natural adjuvant for protein and peptide-based vaccines
KR102793214B1 (ko) 2019-01-30 2025-04-08 보오슈 앤드 롬 인코포레이팃드 가교화 중합체 망상구조물 및 이의 용도
US11673974B2 (en) 2019-04-29 2023-06-13 Bausch & Lomb Incorporated Glycophospholipid polymeric network and use thereof
JP7721539B2 (ja) * 2020-08-14 2025-08-12 国立大学法人 東京大学 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法
CN116057380A (zh) * 2020-08-14 2023-05-02 伊德里斯肿瘤学私人有限公司 用于将包含透明质酸的涂层施加到医疗取样装置的表面上的方法以及提供有该涂层的用于捕获循环肿瘤细胞的医疗取样装置
CN113402633B (zh) * 2021-07-22 2022-04-05 山东大学 一种透明质酸-超氧化物歧化酶结合物及其在皮肤护理产品中的应用
CN114805631A (zh) * 2022-03-01 2022-07-29 吉林省奇健生物技术有限公司 高活性透明质酸-多肽缀合物及其制备方法和应用
CN116239707B (zh) * 2023-05-08 2023-07-14 山东大学 一种胰岛素修饰的肝素衍生物及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553099B1 (fr) 1983-10-11 1989-09-08 Fidia Spa Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
US4636524A (en) 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6153655A (en) 1998-04-17 2000-11-28 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
US6749865B2 (en) 2000-02-15 2004-06-15 Genzyme Corporation Modification of biopolymers for improved drug delivery
IT1317359B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
US7034127B2 (en) 2002-07-02 2006-04-25 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
ITPD20020271A1 (it) * 2002-10-18 2004-04-19 Fidia Farmaceutici Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
AU2006248166B2 (en) * 2005-05-20 2012-11-01 Agency For Science, Technology And Research Aldehyde conjugated flavonoid preparations
RU2343932C1 (ru) * 2007-03-28 2009-01-20 Институт нефтехимии и катализа РАН Способ получения обладающих пониженной растворимостью в воде пленочных материалов на основе модифицированных аминосалициловыми кислотами карбоксилсодержащих полисахаридов
ITMI20071267A1 (it) 2007-06-22 2008-12-23 Fidia Farmaceutici Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative

Also Published As

Publication number Publication date
CA2765739C (en) 2017-05-09
EP2443156A1 (en) 2012-04-25
CN102803297B (zh) 2014-12-10
CN102803297A (zh) 2012-11-28
BR112012000551A2 (pt) 2016-11-16
US20120114602A1 (en) 2012-05-10
CA2765739A1 (en) 2010-12-23
ES2600358T3 (es) 2017-02-08
EP2443156B1 (en) 2016-09-28
SMT201700012T1 (it) 2017-03-08
IT1399351B1 (it) 2013-04-16
WO2010145821A1 (en) 2010-12-23
RU2530649C2 (ru) 2014-10-10
ITMI20091065A1 (it) 2010-12-17
HK1176954A1 (en) 2013-08-09
RU2011151396A (ru) 2013-07-27
MX2011013683A (es) 2012-01-20
US9034624B2 (en) 2015-05-19

Similar Documents

Publication Publication Date Title
SMT201700012B (it) Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi
DK2479174T3 (da) 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf
BRPI1012861A2 (pt) catalisador, e, uso do catalisador
BRPI0821590A2 (pt) Eletrodo médico, conjunto de eletrodos e disposição de conjuntos de eletrodos
BRPI0812134A2 (pt) Anatagonistas de cxcr4 de peptídio cíclico
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0818373A2 (pt) compostos de pelicetal, síntese e aplicações
BRPI0908885A2 (pt) sistemas de varredura
BRPI0818453A2 (pt) sistema de cirurgia não-invasiva de base fotônica
BRPI1014885A2 (pt) "azetidinil diamidas como inibidores de monoacilglicerol lipase."
BR112012012934A2 (pt) ''formulações de espuma isentas de emulsificante, estabilizadas com polímero''
EP2146771A4 (en) INTRAKAVITARY RADIATION SYSTEM
DK3115370T3 (da) Biologisk aktive peptider
BRPI0817065A2 (pt) Produção de óxido de etileno usando concentração fixa de moderador.
BRPI1012156A2 (pt) instrumento endoscópico.
EP2331277A4 (en) BARBELL STRUCTURE OF HIGH STRENGTH AND LIGHT WEIGHT
BR112012008053A2 (pt) fermentação purificação de heparosano k5.
BRPI1006058A2 (pt) "fermentação de carboidrato"
EP2137404A4 (en) WAVE POWER PLANT
BR112012001346A2 (pt) catálise de formulações de resina de epóxido com catalisadores dificilmente solúveis
ITMI20100233A1 (it) Procedimento di produzione di supporto di dialcossimagnesio per catalizzatore per la polimerizzazione di olefine, procedimento di produzione di catalizzatore per la polimerizzazione di olefine impiegante il medesimo e procedimento di polimerizzazione
FR2937857B1 (fr) Membrane chirurgicale antiadherence
BRPI0911578A2 (pt) ensaio de acetaminofeno.
IT1396812B1 (it) Dispositivo per il trasporto di strumenti medicali.
BRPI0909096A2 (pt) uso de conjugados de interleicna-1 no tratamento de diabetes